Sec Form 4 Filing - Euclidean Capital LLC @ PMV Pharmaceuticals, Inc. - 2021-06-11

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Euclidean Capital LLC 2. Issuer Name and Ticker or Trading Symbol PMV Pharmaceuticals, Inc. [ PMVP] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 160 FIFTH AVE, 9TH FL, 3. Date of Earliest Transaction (MM/DD/YY) 06/11/2021 (Street) NEW YORK, NY10010 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 06/11/2021 S 2,324 D $ 33.8 479,062 I See Footnotes ( 1 ) ( 6 ) Common Stock 06/11/2021 S 3,262 D $ 33.8 672,289 I See Footnotes ( 2 ) ( 6 ) Common Stock 06/11/2021 S 3,533 D $ 33.8 728,140 I See Footnotes ( 3 ) ( 6 ) Common Stock 06/11/2021 S 12,237 D $ 33.8 2,521,280 I See Footnotes ( 4 ) ( 6 ) Common Stock 06/11/2021 S 621 D $ 33.8 128,359 I See Footnotes ( 5 ) ( 6 ) Common Stock 06/14/2021 S 4,699 D $ 34.11 474,363 I See Footnotes ( 1 ) ( 6 ) Common Stock 06/14/2021 S 6,593 D $ 34.11 665,696 I See Footnotes ( 2 ) ( 6 ) Common Stock 06/14/2021 S 7,141 D $ 34.11 720,999 I See Footnotes ( 3 ) ( 6 ) Common Stock 06/14/2021 S 24,726 D $ 34.11 2,496,554 I See Footnotes ( 4 ) ( 6 ) Common Stock 06/14/2021 S 1,260 D $ 34.11 127,099 I See Footnotes ( 5 ) ( 6 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Euclidean Capital LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY10010 X Greenland A LLC C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY10010 X Greenland FP LLC C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY10010 X Greenland NFP B Ltd. LEVEL 1, PALM GROVE HOUSE WICKHAM'S CAY ROAD TOWN, TORTOLA, D8 X Greenland NFP LLC C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY10010 X Symmetry Group Ltd. LEVEL 1, PALM GROVE HOUSE WICKHAM'S CAY ROAD TOWN, TORTOLA, D8 X Simons Marilyn C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY10010 X Chhabra Ashvin C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY10010 X SIMONS JAMES H C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY10010 X Signatures /s/ Joseph Cosmai - Euclidean Capital LLC, By: Joseph Cosmai, Manager 06/15/2021 Signature of Reporting Person Date /s/ Joseph Cosmai - Greenland A LLC, By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager 06/15/2021 Signature of Reporting Person Date /s/ Joseph Cosmai - Greenland FP LLC, By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager 06/15/2021 Signature of Reporting Person Date /s/ Joseph Cosmai - Greenland NFP B Ltd., By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager 06/15/2021 Signature of Reporting Person Date /s/ Joseph Cosmai - Greenland NFP LLC, By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager 06/15/2021 Signature of Reporting Person Date /s/ Joseph Cosmai - Symmetry Group Ltd., By: Joseph Cosmai, Vice President & Treasurer 06/15/2021 Signature of Reporting Person Date /s/ Joseph Cosmai, as attorney-in-fact for Marilyn Simons 06/15/2021 Signature of Reporting Person Date /s/ Joseph Cosmai, as attorney-in-fact for Ashvin Chhabra 06/15/2021 Signature of Reporting Person Date /s/ Joseph Cosmai, as attorney-in-fact for James Simons 06/15/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. ( 2 )The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. ( 3 )The shares are held of record by Greenland FP LLC, which is managed by Euclidean. ( 4 )The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. ( 5 )The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. ( 6 )Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.